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ABSTRACT: The global increase in tuberculosis drug resistant which is a threat to its control, require low 
cost method of diagnosis and detection. Available conventional and molecular methods consume time, and are 
expensive for countries with high disease burden. Nitrate Reductase Assay (NRA) and Microscopic 
Observation Drug Susceptibility (MODS) performance to directly detect tuberculosis resistance to four drugs 
was evaluated. The NRA (liquid and solid) and MODS performance of smear-positive sputum samples were 
evaluated; Sensitivities and specificities were compared with Proportion Method (PM). Sensitivity and 
specificity of liquid NRA (LNRA) were 90% and 98% (rifampicin), 81.8% and 100% (isoniazid), 88.9% and 
98.1% (streptomycin), and 57.1% and 94.4% (ethambuthol). Also, the sensitivity and specificity for solid 
NRA (SNRA) were 69.2% and 98.3% (rifampicin); 100% and 100% (isoniazid); 88.9% and 95.2% 
(streptomycin); 70% and 80.6% (ethambuthol). Moreover, For MODS, rifampicin and isoniazid sensitivity 
and specificity was 100%, it was 100% and 98.1% for streptomycin, and 71.4% and 98.2% for ethambuthol. 
At day 14, the results available for LNRA, SNRA and MODS were 93%, 68.5% and 100% respectively. The 
agreement between LNRA and PM was 97% (RIF, INH and SM) and 90% (EMB). For SNRA, it was 93% 
(RIF), 100% (INH), 94% (SM) and 89% (EMB). While for MODS, it was 100% (RIF and INH), 98% (SM) 
and 95% (EMB). Direct NRA and MODS are sensitive, reliable and fast for antituberculosis drug 
susceptibility; they have potential to effectively and reliably detect drug resistant tuberculosis in the low 
resource countries. 
Keywords: Tuberculosis drug resistance; Mycobacterium detection NRA; MODS; Diagnosis. 
1. INTRODUCTION  
Tuberculosis (TB) is an ancient infectious disease, a public health concern and a typical infection of 
the lungs [1]. The increase in TB and resistance to rifampicin and isoniazid, which are vital anti-tuberculosis 
drug, is a global challenge to TB infections control efforts [2]. This is because TB treatment regimens remain 
ineffective, second line therapies which remain limited by economic challenges are required for treatment 
while, the resistant strains are transmissible [3]. In 2017, the WHO estimated that incident cases was 10 
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million while, death cases was 1.3 million. This was a 1.8% decline from 2016. Moreover, in 2018, the 
notified new cases was 7.0 million, an increase from the 2017 which was reported to be 6.4 million and a 
wide increase from the annual notified cases of 5.7-5.8 million in the period 2009-2012. Also, a detection of 
186772 Multidrug Resistant/Rifampicin Resistant-TB (MDR/RR-TB) cases was notified in 2018, an increase 
from the 160684 notified in 2017 [4-6].  
In Nigeria, while the W.H.O. bacteriologically confirmed estimated cases of TB that were tested for 
rifampicin resistance was 65% (new cases) and 88% (retreatment cases); the MDR/RR-TB cases was 4.3% 
(new) and 15% (previous) in 2018 [6]. The treatment of MDR-TB cases could take as long as 24 months 
using expensive second line anti-tuberculosis drugs, some of which are administer by injection. More so, the 
cure rate is much lower (about 60%) compared to the susceptible strains of TB [7]. However, in most low 
income Sub-Saharan African countries, it is only the first line drugs that are available for the treatment of TB 
infections. Thus, MDR-TB prevalence is a concern in the region as its magnitude is largely unknown but the 
W.H.O. estimated cases in the region increased from 2.4% (new cases) and 13% (retreatment cases) in 2013 to 
2.7% (new cases) and 14% (retreatment cases) in 2017 [6, 8]. The cases of MDR-TB that is reported to be on 
the increase necessitate a timely TB diagnosis to effectively manage patients, as well as putting measures for 
effective control and further spread of the infection in place. 
Detection of drug resistant TB using conventional methods on Lowenstein-Jensen (LJ) medium is 
cheap but, it is cumbersome and takes a long time [7]. Commercial liquid automated systems like the 
BACTEC MGIT 960 and line probe assays are fast; nevertheless, the  equipment required are expensive, the 
running costs are high and are technically complex. All these may make them difficult for implementation in 
low resource countries. In addition, the low speed of liquid-based indirect susceptibility prolongs taking 
decisions to manage MDR-TB patients [7, 9]. The fast molecular methods [10-12]; are expensive and require 
manpower that are well-trained [13, 14]. They may therefore be unaffordable for the developing countries and 
may not be practicable for routine use. This therefore necessitates a need for a fast and affordable method that 
can easy detect drug resistant TB especially in low resource nations. 
First description of Nitrate Reductase Assay (NRA) was in 2002 [15]. It was performed on solid 
medium as indirect assay just like the proportion method on L-J media; the liquid based assay has also been 
studied [16, 17]. The principle on which this technique is based is nitrate being utilized and converted by 
Mycobacterium tuberculosis to nitrite that can be detected by adding Griess reagent leading to pink-purple 
colour production [15]. While in some studies, the method has been evaluated [18, 19], the only study in 
Nigeria was by Ani et al. [20] in Jos a city in northern part of the country. 
Microscopic observation drug susceptibility is a low-cost technology based on liquid culture method 
that detects TB resistance [21, 22]. This technique relies on the observation of the characteristic cord-like 
structure of a tissue culture plates with the use of an inverted microscope. The principle upon which the 
method relies include: faster growth of M. tuberculosis in broth culture than on solid media; characteristics 
growth of tubercle bacilli that makes it detected visually using and inverted microscope much earlier than 
when naked eye could view mycobacterial growth on solid media and with incorporation of drugs in the 
medium enable direct susceptibility testing [23]. Elsewhere, this technique was evaluated [9, 24] but no record 
of its evaluation in Nigeria. In this study, the sensitivity of NRA (solid and liquid media) and MODS with PM 
as ‘gold standard’ on Lowenstein Jensen medium for DST of MTB using four first-line anti-tuberculosis drugs 
was evaluated.    
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2. MATERIALS AND METHODS 
2.1. Study area and sample processing 
The study was a cross-sectional, laboratory-based comparative study carried out in Ibadan, Nigeria. 
Processing of the samples (sputum) was done using the N-acetyl-L-cysteine–NAOH–sodium citrate (NALC-
NAOH) decontamination technique. Briefly, in a 15 mL centrifuge tube, equal volume (2 mL) of the sample 
and NALC-NAOH (Mycopep) solution were added. It was tightly capped, voretxed for about 20 seconds and 
left to stand for betewwen 15 and 20 minutes. Phosphate buffer (pH 6.8) was added to 14 mL mark and 
centrifuged for 15 minutes at 3000 x g. The pellet was retained after the supernatant has been carefully 
decanted; and was reconsistituted by mixing with phosphate buffer and was used as the inoculum. 
2.2. Ethical approval 
Ethical approval for this study was obtained from the University of Ibadan/University College 
Hospital Ethical committee with approval number NHREC/05/01/2008a. 
2.3. Nitrate Reductase Assay in liquid media 
Nitrate reducatse assay also called Griess method is based on the principle that Mycobacterium 
tuberculosis are capable of reducing nitrate to nitrite and this is used for biochemical identification of 
mycobacterial species. Nitrite presence can be detected by addition of Griess reagent. The technique was done 
as previouly described [25]. Briefly, in 4.6 mL of 7H9-N medium of which RIF, INH, SM and EMB at 
concentration of 40 µg/mL, 0.2 µg/mL, 8.0 µg/mL and 2.0 µg/mL respectively was incoporated, undiluted 
sample (0.5 mL) was added. Also, 0.5 mL of diluted (1:10 dilution) sample was used to inoculate 4.6 mL of 
7H9-N medium without drug. The inoculated media were incubated at 37oC for 5 days after which an aliquote 
of 1mL of the media without antimicrobial was withdrawn and developed with 0.2 mL fresh griess reagent. 
The mixture was observed for a colour cahnge, and if there was a colour change (strong or weak pink), the 
process was repeated for the culture that contain antibiotics. If colour change was not observed in the tubes 
without antimicrobial, the incubation was continued and process repetaed for 7, 10, 14 and 18 days. 
2.4. Interpretation of LNRA 
If colour change (strong or weak pink) was observed, it was classified as positive and the tubes with 
antibiotics were tested with the griess reagent. If there is no colour cahnge, the tubes were re-incubated and 
the procedure repeated at day 7, 10, 14 and 18 if the need be (Fig. 1). An isolate was considered resistant with 
a colour change in the antibiotic tube greater than 1:10-diluted growth control on the same day [25]. 
2.5. Nitrate Reductase Assay on solid media and microscopic observation drug susceptibility   
The NRA method on solid media was carried out as previouly described [18] with some 
modifications regarding critical concentration of rifampicin antibiotics; while the MODS assay was done as 
described previously [18, 25].  
2.6. Interpretation of SNRA 
After seven days of incubation, 0.5 mL of Griess reagents was added to one drug-free control tube. If 
any colour change (strong or weak pink) was noticed, the corresponding antibiotic-containing tubes were also 
tested and the susceptibility results read. If no colour change was seen in the control tube, the remaining 
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control tubes and the antibiotics tubes were re-incubated. The procedure was then repeated at day 10 and, if 
needed, at day 14 and day 18, using the last growth control tube (Fig. 2). 
2.7. Proportion method (PM) and  quality control 
This was the reference method and was done using Lowestein-Jensen (L-J) medium as previously 
described [27, 28]; while strains of H37Rv (ATCC 27294) and MDR (ATCC 35838) were used as control 
reference strain. Before use, they were freshly subcultured on LJ medium.  
3. RESULTS 
3.1. Performance of liquid NRA 
Among the samples processed, LNRA detected growth in 61 and was compared with PM. An 
excellent agreement (96.7%) for rifampicin, isoniazid and streptomycin was obtained, while the agreement 
observed for ethambuthol was 90.2% (Fig. 1). The sensitivity and specificity of growth detection by LNRA 
and PM of rifampicin resistance was 90% and 98% respectively, whereas, for isoniazid, it was 81.8% and 
100% while, it was 88.9% and 98.1% for streptomycin, and 57.1% and 89.2% for ethambuthol, respectively 
(Table 1). 
 
Table 1. Comparison of PM and LNRA susceptibility (%). 
Drug NRA result Isolates with the proportion results Sensitivity Specificity Predictive values 
 Resistant Susceptible   Positive Negative 
RIF resistant 9 1     
RIF susceptible 1 50 90.0 98.0 90.0 98.0 
INH resistant 9 0     
INH susceptible 2 50 81.8 100 100 96.1 
SM resistant 8 1     
SM susceptible 1 51 88.9 98.1 88.9 98.1 
EMB resistant 4 3     
EMB susceptible 3 51 57.1 94.4 57.1 94.4 
RIF - Rifampicin, INH - Isoniazid, SM - Streptomycin, EMB - Ethambuthol, PM - Proportion method, LNRA - Liquid nitrate reductase assay. 
 
 
Figure 1. Nitrate reductase assay in liquid medium showing positive (growth) and negative (no growth) samples (1 and 5 
positive; 2, 4, 7  negative; 3, 6 and 8 intermediate). 
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3.2. Solid NRA performance 
For SNRA, growth detection was in 72 samples and was compared with the PM. The comparison 
showed that there was an excellent agreement between SRNA and PM for rifampicin (93.1%), isoniazid 
(100%) and streptomycin (94.4%); while a very good agreement (84.7%) was observed for ethambuthol (Fig. 
2). Sensitivity and specificity of growth detection for rifampicin resistance was 69.2% and 98.3% 
respectively, but was 100% and 100% for isoniazid. Moreover, that of streptomycin was 88.9% and 95.2%, 
but was 70% and 98.1% respectively for ethambuthol (Table 2). 
 
Table 2. Comparison of PM and SNRA susceptibility (%). 
Drug NRA result Isolates with the proportion results Sensitivity Specificity Predictive values 
 Resistant Susceptible   Positive Negative 
RIF resistant 9 1 69.2 98.3 90.0 93.5 
RIF susceptible 4 58     
INH resistant 16 0     
INH susceptible 0 56 100 100 100 100 
SM resistant 8 3     
SM susceptible 1 60 88.9 95.2 72.7 98.4 
EMB resistant 7 4     
EMB susceptible 3 58 70 80.6 63.6 95.1 




Figure 2. Nitrate reductase assay tubes showing positive (growth) and negative (no growth) samples (1-3 = no growth;   
4-8 = growth). The bluish color indicates that there was no mycobaterial growth while the pinkish color indicates presence 
of nitrite from nitrate due to presence of mycobacterial growth. 
 
3.3. Performance of MODS 
For MODS, detection of growth was in 62 samples and was compared with PM. The comparison 
showed excellent agreement for rifampicin (100%), isoniazid (100%), and ethambuthol (93.5%), while a very 
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good agreement (88.4%) was also obtained for streptomycin (Fig. 1). The sensitivity and specificity of growth 
detection for both rifampicin and isoniazid resistance was 100% and 100% respectively, while it was 100% 
and 98.1% for streptomycin, it was 71.4% and 98.2% for ethambuthol (Table 3).  
 
Table 3. Comparison of PM and MODS susceptibility (%).  
Drug NRA result Isolates with the proportion results Sensitivity Specificity Predictive values 
 Resistant Susceptible   Positive Negative 
RIF resistant 12 0 100 100 100 100 
RIF susceptible 0 50     
INH resistant 11 0     
INH susceptible 0 51 100 100 100 100 
STR resistant 10 1     
STR susceptible 0 51 100 98.1 90.9 100 
EMB resistant 5 1     
EMB susceptible 2 54 71.4 98.2 83.3 96.4 
RIF - Rifampicin, INH - Isoniazid, SM - Streptomycin, EMB - Ethambuthol, PM - Proportion method, MODS - Microscopic drug 
susceptibility. 
 
3.4. Total performance of the three diagnostic methods 
The total performance of LNRA, SNRA and MODS showed that for LNRA, it was 81.1% 
(sensitivity), 97.6% (specificity), 85.7% (positive predictive value - PPV) and 96.7% (negative predictive 
value - NPV) while, for SNRA, sensitivity was 83.3%, and specificity was 96.6%, while it was 83.3% (PPV) 
and 96.6% (NPV). Also for MODS, it was 95.0% (sensitivity), 99.0% (specificity), 95.0% (PPV) and 99.0% 
(NPV) (Table 4 and Fig. 3). 
 
 
Figure 3. Agreement of the three methods compared to PM. 
PM - Proportion method, LNRA - Liquid nitrate reductase assay, SNRA - Solid nitrate reductase assay, MODS - Microscopic observation 
drug susceptibility. 
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Table 4. Total performance of the techniques (%). 
Drug NRA result Isolates with the proportion results Sensitivity Specificity Predictive values 
 Resistant Susceptible   Positive Negative 
NRA (Broth)       
resistant 30 5 81.1 97.6 85.7 96.7 
susceptible 7 302     
NRA (Solid)       
resistant 40 0     
susceptible 8 228 83.3 97.6 85.7 96.7 
MODS       
resistant 38 2     
susceptible 2 205 95.0 99.0 95.0 99.0 
NRA - Nitrate reductase assay, MODS - Microscopic observation drug susceptibility.  
 
3.5. Turnaround time (TAT) of the methods 
The time between the date of the sample processing (sample inoculation) and when the positive 
result for both mycobacteria detection and susceptibility result was obtained for the three methods are shown 
in Table 5. For LNRA, the TAT was from 5-18 days (mean of 8.7 ± 3.9 days); for SNRA, it was 7-18 days 
(mean of 11.7 ± 4.4 days) while, it ranged from 5-14 days (mean of 7.3 ± 3 days) for MODS. The available 
result at day 14 was 93.0% (LNRA), 68.5% (SNRA) and 100.0% (MODS). However, the TAT of the methods 
was not statistically significant (p = 0.176). 
 
Table 5. The TAT for culture positive samples for the three methods. 
TAT (no 
of days) 
LNRA SNRA MODS 









5 14 24.6 24.6 - 0 0 20 32.8 32.8 
7 22 38.6 63.2 12 21.1 21.1 22 36.1 68.9 
10 9 15.8 79 20 35.1 56.2 18 29.5 98.4 
14 8 14 93 7 12.3 68.5 1 1.6 100 
18 4 7 100 18 31.6 100 - 100 100 
Total 57 100  57 100  61   
TAT - Turnaround time, LNRA - Liquid nitrate reductase assay, SNRA - Solid nitrate reductase assay, MODS - Microscopic observation 
drug susceptibility.  
 
4. DISCUSSION 
In other to initiate effective anti-TB treatment, rapid drug susceptibility result is pivotal. Such rapid 
methods which are also low cost are required in Nigeria and other low resource countries where the disease is 
endemic. Two diagnostic methods RNA (LRNA and SRNA) and MODS compared to PM (gold standard) 
were evaluated.  An excellent agreement (97.7%) obtained in the comparison of LNRA with PM for RIF, INH 
and SM as well as the 90.2% agreement for EMB agrees with the report of another study in India [16]. In 
addition, while excellent agreement (96.2%) was observed between LNRA and PM in this study, a good 
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agreement (86.0%) was observed in another study carried out in Sri Lanka, a low TB prevalent country [29]. 
The sensitivity and specificity of RIF and INH obtained in this study were comparably similar to the report of 
some previous studies [16, 30]. In addition, the sensitivity and specificity obtained for RIF in this study is also 
similar compared to the report from another study in Sri Lanka [29]. 
The TAT for LNRA (5-18 days) with 93.0% of the results that were obtained at day 14 did not agree 
with the 3-9 days previously reported, and the 93.0% results obtained at day 7 from a similar study [30]. 
However, the mean TAT of 8.7 days in this study is shorter compared to the 10 days previously reported [29]. 
Also, the full agreement of SNRA and PM obtained for INH and excellent agreement for RIF is important, 
because the combination of both drugs is the most valuable drug against TB infection. This is also in 
agreement with the report of a recent study in Nepal [31]. 
Except for RIF, the sensitivity obtained for INH, SM and EMB were better compared to the report 
from other studies in Sweden [18] and Nepal [32]. However, the specificity obtained from the present study is 
similar to the latter studies. Also, while total sensitivity and specificity of SNRA obtained in this study agrees 
with the report of Musa et al. [18], there were little discrepancies in the percentage agreement obtained in this 
study for all the antibiotics except for INH that was similar as previously reported by Sethi et al. [32]. 
Furthermore, a lower sensitivity for RIF was obtained in this study compared to the sensitivities reported from 
similar studies in Benin Republic, India and Nepal [19, 25, 31]. However, the percentage agreement obtained 
in this study is similar to the latter studies. 
Moreover, the sensitivities of SNRA for all the antibiotics in this study is similar compared to the 
reported sensitivities from another study in Jos, Nigeria [20]. Apart from the similar sensitivity, specificity, 
PPV and NPV compared to the report of Martin et al. [33], the value for RIF in this study was lower. Also, in 
another study carried out in Tunisia [34], a similar specificity was observed for all the drugs. Furthermore, the 
obtained SNRA results of samples in 10 days for 56.2%, 14 days for 68.5% and 18 days for 100% is similar to 
the 16% samples obtained in 10 days, 64% (14 days) and 100% (18 days) reported by Musa et al. [18], 96% in 
18 days by Affolabi et al. [25] and 93% in 18 days by Boum et al. [17]. However, this observation differs from 
those reported by Bwanga et al. [9], Kammou et al. and recently by Halwai et al. [31].    
The agreement, sensitivities and specificities obtained for all the antibiotics in this present study is a 
good pointer for MODS as a tool for diagnosis of TB and drug resistant detection. The observed agreement in 
this study is comparably similar to the reported agreement for RIF and INH in a related study from Peru and 
Ethiopia [22, 24]. While the sensitivity, specificity, PPV and NPV obtained in this study is similar to that of a 
recent study in India [35], a lower value of the respective parameters was reported for both rifampicin and 
isoniazid in Uganda [9]. Similarly, the total performance of MODS in this study in terms of sensitivity and 
NPV are better compared to the report of  Kirwan et al. [36]. The reason for the disparity might be due to the 
studied samples. While the present study was on pulmonary tuberculosis, the latter study was on lymph node 
tuberculosis. The MODS TAT was the shortest compared to LNRA and SNRA and was also better than the 
MODS evaluation in Uganda [9] but similar to the TAT previously reported in Peru [22]. Moreover, the 
median TAT (7 days) observed in the present study for MODS was the same with that of Bwanga et al. [9] but 
lower than the 9 days by Shiferaw et al. [24].  
In line with the challenges that are common to local laboratories especially developing countries, 
about 40 minutes is required to process one sample using LNRA, about 75 minutes for SNRA and 60 minutes 
for MODS. Using the methods to detect Mycobacterium resistant strains, is fast and easy. For both LNRA and 
SNRA, special equipment is not required, however, MODS requires the use of inverted microscope. Although, 
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training of personnel to use the methods is easy; in order to avoid aerosol generation, sample processing 
should be with care in a biosafety cabinet. Preparation of culture media requires about 40, 75 and 50 minutes 
for LNRA, SNRA and MODS respectively. For LNRA and MODS, cross contamination is possible and to 
some extent with SNRA. The MODS technique has added advantage of good biosafety because once MODS 
plate is sealed it is never opened. The methods are suitable for local laboratories.  
In conclusion, the observation from this study showed that direct NRA (liquid and solid) and MODS 
on sputum smear positive samples are highly sensitive, accurate, reliable, easy and fast methods for 
tuberculosis and drug resistant tuberculosis detection and can be implemented in low resource countries.  
Limitation of the study: The limitation of the study is the small sample size.   
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